Remus Pharmaceuticals Ltd (REMP)

Currency in INR
685.30
-14.50(-2.07%)
Closed·
REMP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
672.00689.90
52 wk Range
580.001,139.50
Key Statistics
Bid/Ask
685.00 / 695.00
Prev. Close
699.8
Open
684
Day's Range
672-689.9
52 wk Range
580-1,139.5
Volume
3.9K
Average Volume (3m)
4.25K
1-Year Change
-32.1619%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
REMP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
10-11-2025
EPS / Forecast
18.33 / --
Revenue / Forecast
4B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 27.37%
Dividend Yield
0.14%
Industry Median 0.76%
Annualised payout
1.00
Paid annually
5-Years Growth
-
Growth Streak

REMP Income Statement

Compare REMP to Peers and Sector

Metrics to compare
REMP
Peers
Sector
Relationship
P/E Ratio
23.8x46.2x−0.5x
PEG Ratio
3.020.290.00
Price/Book
2.6x4.4x2.6x
Price / LTM Sales
1.1x3.5x3.2x
Upside (Analyst Target)
-21.6%48.8%
Fair Value Upside
Unlock−1.0%6.9%Unlock

Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceuticals products and allied products in India and internationally. It is involved in trading of active pharmaceutical ingredient, as well as provides technical and consultancy services to various distributors and contract manufacturing services. The company offers tablet, hard and soft gelatine capsules, liquid and lyophilized injections, as well as pre-filled syringe, infusions, inhalers, nebulizers, nasal sprays and solutions, eye drops, creams, gels, ointments, suspensions, oral solutions and suspensions, sachets, and ophthalmic and other dosage forms. It also exports its products. Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.

Employees
68
Market
India

FAQ

What Is the Remus Pharmaceuticals (REMP) Share Price Today?

The Remus Pharmaceuticals share price today is 685.30.

What is the current Remus Pharmaceuticals (REMP) share price and day range?

As of 01-05-2026, the Remus Pharmaceuticals share price is 685.30, with a previous close of 699.80. The share price has ranged from 672.00 to 689.90 today, while the 52-week range spans from 580.00 to 1,139.50.

What Is the Remus Pharmaceuticals Market Cap?

As of today, Remus Pharmaceuticals market cap is 7.99B.

Does Remus Pharmaceuticals Pay Dividends? What's The Current Dividend Yield?

The Remus Pharmaceuticals dividend yield is 0.14%.

What Is Remus Pharmaceuticals's Earnings Per Share (TTM)?

The Remus Pharmaceuticals EPS (TTM) is 27.37.

From a Technical Analysis Perspective, Is REMP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does Remus Pharmaceuticals Trade On?

Remus Pharmaceuticals is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Remus Pharmaceuticals?

The stock symbol for Remus Pharmaceuticals is "REMP."

How Many Times Has Remus Pharmaceuticals Stock Split?

Remus Pharmaceuticals has split 2 times.

How Many Employees Does Remus Pharmaceuticals Have?

Remus Pharmaceuticals has 68 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.